Stocks MBC Financial statements
Financial statementsMasterBrand, Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 5 fiscal years, taken from the XBRL data MasterBrand, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2021 | FY2023 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Revenue | 2,855 | 3,276 | 2,726 | 2,700 | 2,735 |
| Cost of revenue | 2,071 | 2,335 | 1,825 | 1,823 | 1,907 |
| Gross profit | 784 | 941 | 901 | 877 | 828 |
| Selling, general and administrative | 528 | 649 | 570 | 603 | 668 |
| Operating income | 234 | 203 | 306 | 236 | 119 |
| Interest expense | 0 | 2.2 | 65.2 | 74 | 74.1 |
| Interest income | 4.6 | 12.9 | 0 | 0 | |
| Other non-operating income | -0.6 | -0.6 | -2.4 | 2.3 | 1.4 |
| Pre-tax income | 238 | 213 | 239 | 168 | 46.3 |
| Income tax | 55.7 | 58 | 56.7 | 42.4 | 19.6 |
| Net income | 183 | 155 | 182 | 126 | 26.7 |
| EBITDA | 279 | 251 | 355 | 293 | 187 |
| EPS, basic | 1.43 | 1.21 | 1.42 | 0.99 | 0.21 |
| EPS, diluted | 1.43 | 1.20 | 1.40 | 0.96 | 0.21 |
| Shares, basic (weighted) | 128 | 128 | 128 | 127 | 127 |
| Shares, diluted (weighted) | 128 | 129 | 130 | 131 | 129 |
Balance sheet
| FY2021 | FY2023 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Cash and equivalents | 141 | 101 | 149 | 121 | 183 |
| Receivables | 290 | 203 | 191 | 150 | |
| Inventory | 373 | 250 | 276 | 269 | |
| Other current assets | 66.2 | 75.7 | 62.7 | 93.1 | |
| Total current assets | 830 | 677 | 651 | 696 | |
| Property, plant and equipment | 353 | 357 | 482 | 503 | |
| Lease right-of-use assets | 52.3 | 60.1 | 66.4 | 189 | |
| Goodwill | 926 | 924 | 925 | 1,126 | 1,128 |
| Intangible assets | 350 | 336 | 571 | 548 | |
| Other non-current assets | 20.5 | 27.2 | 34.1 | 37.1 | |
| Total assets | 2,529 | 2,382 | 2,930 | 3,100 | |
| Accounts payable | 219 | 151 | 181 | 204 | |
| Accrued liabilities | 49 | 67.6 | 54.9 | 63.3 | |
| Short-term debt | 17.5 | 17.6 | 0 | 0 | |
| Total current liabilities | 411 | 349 | 395 | 416 | |
| Long-term debt | 962 | 690 | 1,008 | 975 | |
| Lease liabilities | 40.7 | 46.3 | 55 | 175 | |
| Other non-current liabilities | 7.4 | 10.5 | 15 | 18.8 | |
| Total liabilities | 1,520 | 1,188 | 1,635 | 1,756 | |
| Total debt | 979 | 708 | 1,020 | 975 | |
| Paid-in capital | 0 | 17.8 | 39.7 | 55.8 | |
| Retained earnings | 1,023 | 1,205 | 1,330 | 1,357 | |
| Treasury stock | -0.1 | -26.1 | -44 | -70.4 | |
| Other comprehensive income | -14.5 | -3.7 | -32.7 | 0.8 | |
| Shareholders' equity | 2,454 | 1,009 | 1,194 | 1,295 | 1,345 |
| Total equity | 2,454 | 1,009 | 1,194 | 1,295 | 1,345 |
| Total liabilities and equity | 2,529 | 2,382 | 2,930 | 3,100 | |
| Shares outstanding | 128 | 127 | 128 | 127 |
Cash flow statement
| FY2021 | FY2023 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Net income | 183 | 155 | 182 | 126 | 26.7 |
| Depreciation and amortization | 44.4 | 47.3 | 49 | 57.1 | 67.9 |
| Stock-based compensation | 9.3 | 10.9 | 17.8 | 21.9 | 16.1 |
| Deferred income tax | -7.7 | 2.3 | -5.7 | 4.6 | 12.8 |
| Change in receivables | -72.2 | 13.5 | 86.2 | 21.3 | 24 |
| Change in inventory | -58.5 | -70.1 | 124 | -10.7 | 8 |
| Change in payables | 44.7 | 18.3 | -69.4 | 23.8 | 15.7 |
| Cash from operations | 148 | 236 | 406 | 292 | 196 |
| Capital expenditures | -51.6 | -55.9 | -57.3 | -80.9 | -78.2 |
| Acquisitions | 0 | 0 | -515 | 0 | |
| Cash from investing | -51.5 | -55.9 | -56.9 | -581 | -74.4 |
| Debt issued | 0 | 750 | 0 | 700 | 0 |
| Debt repaid | 0 | 0 | -37.5 | -713 | |
| Share buybacks | 0 | 0 | -22 | -6.5 | -18.1 |
| Cash from financing | -110 | -215 | -300 | 270 | -65.7 |
| Exchange rate effect | 0.1 | -4.7 | -1.2 | -7.9 | 6.7 |
| Net change in cash | -12.9 | -40.3 | 47.6 | -27.1 | 62.3 |
| Free cash flow | 96.6 | 180 | 348 | 211 | 118 |
| Income taxes paid | 15.3 | 10.3 | 68.5 | 40.7 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 26.9% | Gross profit / revenue. |
| Operating margin | -1.1% | Operating income / revenue. |
| EBITDA margin | 1.7% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | -3.8% | Pre-tax income / revenue. |
| Net margin | -3.5% | Net income / revenue. |
| FCF margin | 2.7% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 5.3% | Cash from operations / revenue. |
| Return on equity (ROE) | -4.9% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | -2.2% | Net income / average total assets. |
| Return on invested capital (ROIC) | -0.8% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| SG&A / revenue | 26.2% | Selling, general and administrative expense / revenue. |
| Stock-based pay / revenue | 0.8% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 2.7% | Capital expenditures / revenue. |
| D&A / revenue | 2.8% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 1.3% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | -5.8% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit growth, 1y | -5.6% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | -4.2% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating income growth, 1y | -49.5% | Operating income vs the same period a year earlier. Only from a positive base. |
| Operating income CAGR, 3y | -16.3% | Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA growth, 1y | -36.2% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | -9.3% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income growth, 1y | -78.8% | Net income vs the same period a year earlier. Only from a positive base. |
| Net income CAGR, 3y | -44.4% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EPS growth, 1y | -78.1% | EPS vs the same period a year earlier. Only from a positive base. |
| EPS CAGR, 3y | -44.1% | Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | -33.0% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | -6.0% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | -44.3% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 3y | -13.2% | Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value growth, 1y | 3.9% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 10.0% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets growth, 1y | 5.8% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 7.0% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Share count change, 1y | -1.3% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 0.0% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 1.76x | Current assets / current liabilities. |
| Quick ratio | 0.81x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.40x | (Cash + short-term investments) / current liabilities. |
| Debt / equity | 0.71x | Total debt / shareholders' equity. Not shown when equity is negative. |
| Debt / assets | 31.0% | Total debt / total assets. |
| Liabilities / assets | 56.1% | Total liabilities / total assets. |
| Net debt | $1.15B | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Net debt / EBITDA | 24.8x | Net debt / EBITDA (twelve months), when EBITDA is positive. |
| Interest coverage | -0.42x | Operating income / interest expense. |
| Working capital | $458.0M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 49.3% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | -$238.4M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.62x | Revenue / average total assets. |
| Fixed asset turnover | 3.33x | Revenue / average property, plant and equipment. |
| Inventory turnover | 4.66x | Cost of revenue / average inventory. |
| Days inventory | 78 days | 365 x average inventory / cost of revenue. |
| Receivables turnover | 11.2x | Revenue / average receivables. |
| Days sales outstanding | 32 days | 365 x average receivables / revenue. |
| Days payables | 45 days | 365 x average accounts payable / cost of revenue. |
| Cash conversion cycle | 66 days | Days inventory + days sales outstanding - days payables. |
| Capex / operating cash flow | 49.8% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | -$0.63 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $18.08 | Revenue / diluted weighted shares. |
| FCF per share | $0.48 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $0.96 | Cash from operations / diluted weighted shares. |
| Book value per share | $9.68 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | -$1.17 | Tangible book value / shares outstanding. |
| Cash per share | $1.19 | (Cash + short-term investments) / shares outstanding. |
| Buybacks / FCF | 0.0% | Share buybacks / free cash flow, when free cash flow is positive. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $1.47B | Share price x shares outstanding. |
| Enterprise value | $2.62B | Market cap + total debt - cash - short-term investments. |
| P/S | 0.53x | Market cap / revenue. |
| P/B | 0.75x | Market cap / shareholders' equity. Only when equity is positive. |
| P/FCF | 19.8x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 9.93x | Market cap / cash from operations, when positive. |
| EV/Sales | 0.94x | Enterprise value / revenue. |
| EV/EBITDA | 56.6x | Enterprise value / EBITDA, when both are positive. |
| EV/FCF | 35.2x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 5.1% | Free cash flow / market cap. |
| Earnings yield | -6.6% | Net income / market cap (the inverse of P/E). |
| Shareholder yield | 0.0% | (Dividends paid + share buybacks) / market cap. |
What was MasterBrand, Inc.'s revenue in fiscal 2025?
MasterBrand, Inc. reported revenue of $2.73B for fiscal 2025, 1.3% higher than the year before.
Was MasterBrand, Inc. profitable in fiscal 2025?
Yes. Net income was $26.7M, a net margin of 1%.
How much free cash flow did MasterBrand, Inc. generate in fiscal 2025?
Cash from operations of $195.7M minus capital expenditures of $78.2M left free cash flow of $117.5M.